DNA synthesis provider Twist Bioscience attracts $27 mln

San Francisco-based Twist Bioscience, a provider of DNA synthesis, has raised $27 million in funding. The investors were Biomatics Capital, Reinet Fund S.C.A., F.I.S., NFT Investment Limited, KANGMEI Group, Bay City Capital GF Xinde Life Science Investment Fund, 3W Partners Capital and Ditch Plains Capital Management LP.

North AmericaUSBriefs